Peddle, C., & MacLaren, R. (2021). Development of all-in-one CRISPR/Cas9 and CRISPRi AAV constructs to treat autosomal dominant retinitis pigmentosa.
Cita Chicago Style (17a ed.)Peddle, CF, y RE MacLaren. Development of All-in-one CRISPR/Cas9 and CRISPRi AAV Constructs to Treat Autosomal Dominant Retinitis Pigmentosa. 2021.
Cita MLA (9a ed.)Peddle, CF, y RE MacLaren. Development of All-in-one CRISPR/Cas9 and CRISPRi AAV Constructs to Treat Autosomal Dominant Retinitis Pigmentosa. 2021.
Precaución: Estas citas no son 100% exactas.